Clinical and kinomic analysis identifies peripheral blood mononuclear cells as a potential pharmacodynamic biomarker in metastatic renal cell carcinoma patients treated with sunitinib

magnitude as those in GD di€erence panel. The di€er- ence vectors show that while the GD model is in agreement with the observations throughout most of the magnetosheath, in the

In a multivariate Cox model, poor prognosis according to the Heng criteria and hilar fat infiltration were the only two factors that remained significantly associated with poor

12 Following the results of Checkmate 214, the combination of nivolumab plus ipilimumab is now recommended as first-line therapy for patients with intermediate or

The present study was designed first, to determine whether angptl4 mRNA expression is a useful marker of ccRCC in a large and comprehensive retrospective series of primary

Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy.. Solène-Florence Kammerer-Jacquet,

Key words : kidney ; renal angiomyoadenomatous tumor ; clear cell papillary renal cell carcinoma ; VHL gene ; renal cell carcinoma with leiomyomatous stroma ; relationship...

First, we compared the expansions of PBMCs from 60 EOC patients (EOC PBMCs) and from 13 healthy female donors after a specific Vc9Vd2 cell stimulation with a single dose of either

The aim of the present study was to optimize a cell culture protocol (including quantity of cells, culture duration, and positive control) to obtain reproducible cytokine and